Tower Research Capital (TRC)’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

Tower Research Capital (TRC)’s Portfolio SKBI Stock Details SKBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-181	Closed	–	–	5634
2015 Q3	$0	Sell	181 -765	-81%	-$1.23K	﹤0.01%	5460
2015 Q2	$3K	Buy	946 +462	+95%	+$1.58K	﹤0.01%	3654
2015 Q1	$2K	Sell	484 -255	-35%	-$1.08K	﹤0.01%	3942
2014 Q4	$4K	Buy	+739	New	+$3.19K	﹤0.01%	3016
2014 Q2	–	Sell	-818	Closed	-$5K	–	5170
2014 Q1	$5K	Buy	+818	New	+$4.14K	﹤0.01%	3353
2013 Q4	–	Sell	-454	Closed	-$3K	–	5278
2013 Q3	$3K	Buy	+454	New	+$1.12K	﹤0.01%	4029

Other funds holding SKBI

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Tower Research Capital (TRC)'s SKBI Position: Q4 2015 in Review

Tower Research Capital (TRC) sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q4 2015, closing a stake of 181 shares.

Tower Research Capital (TRC) first reported a position in SKBI in Q3 2013 and held it in 6 quarters. The position peaked at $5K in Q1 2014. 1 fund tracked by Wall St. Rank holds SKBI as of Q4 2015.

Tower Research Capital (TRC) reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q4 2015 after selling out during the quarter.
Tower Research Capital (TRC) sold 181 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q4 2015.
Tower Research Capital (TRC) first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q3 2013 and held it in 6 quarters.
Tower Research Capital (TRC)'s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $5K in Q1 2014.
1 fund tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q4 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2015, filed 10 Feb 2016.